Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,973.00
Ask: 1,976.00
Change: -27.00 (-1.35%)
Spread: 3.00 (0.152%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Tesco And Sainsbury's Beaten By Morrisons

Tue, 30th Jun 2015 10:17

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 WINNERS
-------
Hikma Pharmaceuticals, up 0.6%. The pharmaceutical company is among bidders for Boehringer Ingelheim GmbH's Roxane Labs business in the US, Bloomberg reported citing people familiar with the matter. The report said that other potential buyers for the generic pharmaceutical unit, which may fetch as much as EUR2 billion or USD2.2 billion, include Mallinckrodt and Perrigo Co. A decision on the winner could be made within weeks, though the German drugmaker may still choose to keep the asset.
-------
FTSE 100 LOSERS
-------
Tesco, down 2.1%, J Sainsbury, down 1.6%. Sainsbury's and Tesco came in joint second place out of the big four in the Kantar Worldpanel UK's grocery market data published on Tuesday, both experiencing an annual sales decline of 1.3% in the period. Sainsbury's sales were at GBP4.18 billion, down from GBP4.23 billion a year before, as its market share declined to 16.5% from 16.7%, while Tesco sales fell to GBP7.24 billion from GBP7.34 billion, as its market share dropped to 28.6% from 28.9%. Wm Morrison Supermarkets, whose shares are down 0.3%, was for the second month in a row the only member of the big four UK supermarkets to increase sales.
-------
FTSE 250 WINNERS
-------
Home Retail Group, up 3.5%. Morgan Stanley upgraded the owner of the Argos general merchandise chain and the Homebase DIY chain to Overweight from Equal Weight, lifting its price target to 180 pence from 170p.

St Modwen Properties, up 2.1%. The regeneration property company said it expects to see positive momentum continue into the second half of its financial year after reporting a jump in pretax profit for the first. It made a GBP177.6 million pretax profit in the six months ended May 31, compared with GBP48.6 million in the corresponding period of the prior year. St. Modwen also was upgraded by Numis to Buy from Add, and its price target lifted to 570p from 471p.
-------
FTSE 250 LOSERS
-------
Northgate, down 7.4%. The commercial light vehicle rental company said pretax profit surged in its 2015 financial year as revenue rose across both hire and sale business, prompting the company to hike its dividend payout by nearly half. However, N+1 Singer retains its Hold recommendation due to currency headwinds and depreciation. Meanwhile, Numis downgrades the stock to Hold from Add, raising its price target to 640p from 612p. Though saying Northgate results were "impressive", Numis also notes forex headwinds and depreciation as reasons to be cautious.

Ocado Group, down 1.7%. The online grocery business reported a small decline in profit in the first half of its financial year even though sales grew, as it booked costs associated with investments, distribution and administration. It said pretax profit in the 24 weeks ended May 17 slipped to GBP7.2 million from GBP7.5 million in the same period the year before, despite revenue rising 18% to GBP507.7 million from GBP429.7 million. Shore Capital said it retains a Sell recommendation on the company after the results.

Ultra Electronics, down 1.4%. Berenberg downgraded the defence company to Sell from Hold, cutting its price target to 1,600p from 1,600p.
-------
AIM ALL-SHARE WINNERS
-------
Taihua, up 17%. The chinese pharmaceutical company doubled its pretax profit in 2014 despite lower revenue, thanks primarily to robust sales of its Forsythia product and due to lower inventory provisioning. It said its pretax profit for the year was CNY6.6 million, up from CNY3.3 million a year earlier, despite revenue falling to CNY50.9 million from CNY52.3 million.

Mountfield Group, up 7.3%. The company said the review of its Mountfield Building Group business is already producing measurable benefits. It said the review of the building group business led to a change in focus from carrying out projects with a high risk, fixed-price nature to targeting works directly awarded by clients, which offer lower risks and better margins. Those changes have resulted in a significantly improved trading performance for the division in the year to date, Mountfield said.
-------
AIM ALL-SHARE LOSERS
-------
William Sinclair Holdings, down 27%. The company, which makes gardening products, said it is arranging meetings with investors to test demand for a sizeable share placing, while warning that progress on funding is required in the next few weeks. It said it is still considering its strategic options, with the process now beyond the first phase and the company receiving numerous signs of interest, following a review of the business.

Strat Aero, down 22%. The company said its revenue in the first half of 2015 has been weaker than expected as it published its 2014 results. Strat Aero said revenue in the year to date has been "considerably lower" than its expectations and said it was difficult to predict how the growth of the Unmanned Aerial Vehicle, or drone, market will pan out. It said its pretax loss for the year to December 31 was USD1.2 million, on revenue of USD630,685. No comparable figures were provided.

Sweett Group, down 15%. The construction and building consultancy scrapped its dividend after swinging to a loss in its 2015 financial year, hit by goodwill charges and a decline in revenue. It swung to a pretax loss of GBP1.1 million in the year to the end of March, compared to a GBP2.8 million profit a year earlier, due primarily to a GBP2.4 million goodwill impairment charge it booked related to a probe by the UK's Serious Fraud Office into the conduct of a former employee of its Cyril Sweet International subsidiary in the Middle East.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.